Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

You wouldn’t think you could live when both your heart and lungs are failing, but there is technology that makes it possible.

At the 35th annual Extracorporeal Life Support Services (ELSO) conference, Rhode Island and Hasbro Children's Hospitals were ...